Zdrowie i gospodarka · 20/05/2003

FDA Releases Guidance for Industry on INDs for Phase 2 and Phase 3 Studies; Chemistry, Manufacturing, and Controls Information

The Food and Drug Administration (FDA) has made available a guidance document for the pharmaceutical industry, outlining recommendations for sponsors of investigational new drug applications (INDs) on chemistry, manufacturing, and controls documentation for phase 2 and 3 studies